Explore 3 Stock Ideas & Industry Insights Download Free Report

News

Estee Lauder Director Barshefsky Reports Stock Option Exercise

Director Charlene Barshefsky filed a Form 4 with the SEC on September 10, 2026, disclosing the exercise of stock options and a subsequent sale of Class A Common Stock of Estee Lauder Companies Inc. (NYSE:EL) on September 9, 2026.

Anjali Anand | 10 September 2026

PROCEPT BioRobotics CFO Sells 373 Shares in Tax Withholding Transaction

Kevin Waters, Executive Vice President and CFO of PROCEPT BioRobotics Corp (NASDAQ:PRCT), filed a Form 4 on September 10, 2026, disclosing the sale of 373 shares of common stock on September 9, 2026, as part of the company's sell-to-cover process for tax withholding obligations.

Shwetambri Chauhan | 10 September 2026

PROCEPT BioRobotics CTO Sells 373 Shares for Tax Withholding

Barry L. Templin, Executive Vice President and Chief Technology Officer of PROCEPT BioRobotics Corp (NASDAQ:PRCT), filed a Form 4 on September 10, 2026, disclosing the sale of 373 shares of common stock on September 9, 2026, in connection with the vesting of restricted stock …

Manish Choudhary | 10 September 2026

PROCEPT BioRobotics EVP Sells 297 Shares via Tax Withholding

Alaleh Nouri, Executive Vice President, Chief Legal Officer, and Corporate Secretary of PROCEPT BioRobotics Corp (NASDAQ:PRCT), filed a Form 4 on September 10, 2026, disclosing the sale of 297 shares of common stock on September 9, 2026, in connection with a tax withholding obligation.

Aakashdeep | 10 September 2026

Strata Critical Medical Officer Reports Share Withholding

Amir Cohen, Chief Accounting Officer of Strata Critical Medical, Inc., filed a statement of changes in beneficial ownership on September 10, 2026, reporting a transaction dated September 8, 2026.

Manish Choudhary | 10 September 2026

Strata Critical Medical CEO Verdetto RSU Tax Withholding

Louis R. Verdetto, CEO of Clinical Services at Strata Critical Medical, Inc. (NASDAQ:SRTA), filed a Form 4 on September 10, 2026, disclosing a share withholding transaction dated September 8, 2026, related to the vesting of restricted stock units.

Manish Choudhary | 10 September 2026

BioLife Solutions CFO Reports RSU Tax Withholding Transaction

Troy Wichterman, Chief Financial Officer of BioLife Solutions Inc, filed a Form 4 on September 10, 2026, disclosing the disposition of 1,026 shares of common stock on September 8, 2026, to satisfy tax withholding obligations arising from the release of restricted stock units.

Anjali Anand | 10 September 2026

BioLife Solutions EVP Shares Withheld for Tax on RSU Release

Aby J. Mathew, Executive Vice President and Chief Scientific Officer of BioLife Solutions Inc, filed a Form 4 on September 10, 2026, disclosing a share withholding transaction dated September 8, 2026, related to the release of restricted stock units.

Anjali Anand | 10 September 2026

Appian Corp CEO Sells 45,000 Shares in Rule 10b5-1 Plan

A Form 4 filed on September 10, 2026, disclosed that Matthew W. Calkins, CEO, President, and Director of Appian Corp (NASDAQ:APPN), sold a total of 45,000 shares of Class A Common Stock on September 8, 2026, under a pre-established Rule 10b5-1 trading plan.

Nitish Kishor | 10 September 2026

BioLife Solutions CMO Reports RSU Tax Withholding Transaction

Todd Berard, Chief Marketing Officer of BioLife Solutions Inc, filed a Form 4 on September 10, 2026, disclosing a disposition of 356 shares of common stock on September 8, 2026, to satisfy tax withholding obligations tied to the release of restricted stock units.

Anjali Anand | 10 September 2026
Support

Hi! How can we help you today?

Loading…